IKK/nuclear factor-kappaB and oncogenesis: roles in tumor-initiating cells and in the tumor microenvironment

Adv Cancer Res. 2014:121:125-145. doi: 10.1016/B978-0-12-800249-0.00003-2.

Abstract

The IKK/nuclear factor-kappaB pathway (NF-κB) is critical in proper immune function, cell survival, apoptosis, cellular proliferation, synaptic plasticity, and even memory. While NF-κB is crucial for both innate and adaptive immunity, defective regulation of this master transcriptional regulator is seen in a variety of diseases including autoimmune disease, neurodegenerative disease, and, important to this review, cancer. While NF-κB functions in cancer to promote a number of critical oncogenic functions, here we discuss the importance of the NF-κB signaling pathway in contributing to cancer through promotion of the tumor microenvironment and through maintenance/expansion of tumor-initiating cells, processes that appear to be functionally interrelated.

Keywords: Cancer-associated fibroblast; Cytokine; Nuclear factor-kappaB; Regulatory T lymphocyte; Stroma; Tumor-associated macrophage; Tumor-initiating cell.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carcinogenesis* / genetics
  • Carcinogenesis* / metabolism
  • Carcinogenesis* / pathology
  • Humans
  • I-kappa B Kinase / physiology*
  • NF-kappa B / physiology*
  • Neoplasms / etiology
  • Neoplasms / pathology
  • Neoplastic Stem Cells / physiology*
  • Tumor Microenvironment / physiology*

Substances

  • NF-kappa B
  • I-kappa B Kinase